Erlotinib treatment of meningeal carcinomatosis in lung cancer: more is better

被引:7
作者
Cessot, A. [1 ]
Blanchet, B. [2 ]
Goldwasser, F. [1 ]
机构
[1] Univ Paris 05, Dept Med Oncol, Paris, France
[2] Cochin Teaching Hosp, Dept Pharmacol, Paris, France
关键词
DOSE WEEKLY ERLOTINIB; METASTASES;
D O I
10.1093/annonc/mdu261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2093 / 2094
页数:3
相关论文
共 4 条
[1]   High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer [J].
Clarke, Jennifer L. ;
Pao, William ;
Wu, Nian ;
Miller, Vincent A. ;
Lassman, Andrew B. .
JOURNAL OF NEURO-ONCOLOGY, 2010, 99 (02) :283-286
[2]   Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung Cancer [J].
Fukudo, Masahide ;
Ikemi, Yasuaki ;
Togashi, Yosuke ;
Masago, Katsuhiro ;
Kim, Young Hak ;
Mio, Tadashi ;
Terada, Tomohiro ;
Teramukai, Satoshi ;
Mishima, Michiaki ;
Inui, Ken-ichi ;
Katsura, Toshiya .
CLINICAL PHARMACOKINETICS, 2013, 52 (07) :593-609
[3]   "Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer [J].
Grommes, Christian ;
Oxnard, Geoffrey R. ;
Kris, Mark G. ;
Miller, Vincent A. ;
Pao, William ;
Holodny, Andrei I. ;
Clarke, Jennifer L. ;
Lassman, Andrew B. .
NEURO-ONCOLOGY, 2011, 13 (12) :1364-1369
[4]   High-dose, weekly erlotinib is not an effective treatment in EGFR-mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinib [J].
Kuiper, J. L. ;
Heideman, D. A. M. ;
Thunnissen, E. ;
van Wijk, A. W. ;
Postmus, P. E. ;
Smit, E. F. .
EUROPEAN JOURNAL OF CANCER, 2014, 50 (07) :1399-1401